Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) EBT Margin (2020 - 2025)

Historic EBT Margin for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to 3.37%.

  • Bioventus' EBT Margin rose 71500.0% to 3.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.61%, marking a year-over-year increase of 135500.0%. This contributed to the annual value of 8.57% for FY2024, which is 150700.0% up from last year.
  • Per Bioventus' latest filing, its EBT Margin stood at 3.37% for Q3 2025, which was up 71500.0% from 6.98% recorded in Q2 2025.
  • Bioventus' EBT Margin's 5-year high stood at 29.9% during Q2 2021, with a 5-year trough of 101.47% in Q4 2022.
  • For the 5-year period, Bioventus' EBT Margin averaged around 13.58%, with its median value being 4.23% (2024).
  • In the last 5 years, Bioventus' EBT Margin plummeted by -985800bps in 2022 and then surged by 946900bps in 2023.
  • Over the past 5 years, Bioventus' EBT Margin (Quarter) stood at 2.11% in 2021, then tumbled by -1123bps to 25.78% in 2022, then soared by 76bps to 6.21% in 2023, then skyrocketed by 133bps to 2.06% in 2024, then surged by 64bps to 3.37% in 2025.
  • Its last three reported values are 3.37% in Q3 2025, 6.98% for Q2 2025, and 2.76% during Q1 2025.